Conavi Medical Corp.
CNVIF
$0.362
$0.038211.80%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 72.97% | 34.17% | 31.90% | -124.18% | -- |
| Total Depreciation and Amortization | -17.57% | -33.08% | -30.74% | 8.30% | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -80.62% | -- |
| Total Other Non-Cash Items | -120.09% | -175.84% | -178.47% | 4,784.36% | -- |
| Change in Net Operating Assets | -212.17% | 487.69% | 500.86% | -20.17% | -- |
| Cash from Operations | -40.23% | -13.73% | -17.67% | 17.36% | -- |
| Capital Expenditure | 94.55% | 82.98% | 82.39% | -1.57% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 100.00% | 1,926.12% | 1,988.10% | -10.22% | -- |
| Cash from Investing | 95.86% | 789.29% | 813.20% | -3.35% | -- |
| Total Debt Issued | -- | -- | -- | 767.32% | -- |
| Total Debt Repaid | -91.93% | -47.61% | -47.61% | 50.87% | -- |
| Issuance of Common Stock | -- | 168,100.00% | 168,100.00% | -100.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 301.06% | 1,722.16% | 1,778.25% | -80.07% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 965.41% | 105.01% | 105.18% | -111.63% | -- |